Key result
Intratubular infusion of the nitric oxide synthase inhibitor L-NNA increased tubuloglomerular feedback sensitivity and reactivity, decreasing the turning point from 19.8 to 15.2 nl/min.
Why the study?
Does intratubular infusion of L-NNA alter tubuloglomerular feedback sensitivity and reactivity in anesthetized rats?
Does intratubular infusion of L-NNA alter tubuloglomerular feedback sensitivity and reactivity in anesthetized rats?
Locally produced nitric oxide decreases the sensitivity of the tubuloglomerular feedback mechanism and regulates glomerular capillary pressure in rats.
Answers are grounded in this paper and cite their sources.
Supports nitric oxide attenuation of tubuloglomerular feedback in rats; leaves open translation to human glomerular hemodynamics.
This study was designed to compare the effects of systemic and intratubular infusions of the nitric oxide (NO) synthase inhibitor N omega-nitro-L-arginine (L-NNA) on the tubuloglomerular feedback (TGF) mechanism in anesthetized rats. We recently showed that intravenous infusion of L-NNA led to increases in mean arterial blood pressure (Pa), proximal tubular stop-flow pressure (Psf), and enhanced TGF sensitivity and reactivity. To avoid major systemic effects, in this study TGF was studied after intratubular NO inhibition. Intratubular infusion of L-NNA (10(-3) M) yielded similar results as shown with intravenous infusion, without systemic effects. TGF sensitivity and reactivity were increased, indicated by decreased turning point (TP) from 19.8 +/- 1.0 to 15.2 +/- 0.7 nl/min and increased delta Psf from 10.0 +/- 0.8 to 23.9 +/- 1.9 mmHg (24.3 vs. 59.1%). L-NNA at a concentration of 10(-4) M showed significant changes in both TP (from 20.9 +/- 1.1 to 17.8 +/- 1.0 nl/min) and delta Psf (from 7.6 +/- 0.6 to 13.9 +/- 0.7 mmHg), whereas 10(-5) M only increased delta Psf (9.7 +/- 1.0 vs. 12.1 +/- 1.1 mmHg). However, at low tubular perfusion rates Psf was not influenced by L-NNA. The early proximal flow rate (EPFR) showed no change at low tubular perfusion rates with L-NNA. At maximal TGF activation (40 nl/min), delta EPFR was increased from 34% in control to 62%. Our results suggest that NO not only regulates glomerular capillary pressure but also decreases the sensitivity of the TGF mechanism.
No takes yet. Share an insight, caveat, or question.
Thorup et al. (1994) studied Tubuloglomerular feedback mechanism. L-NNA (N omega-nitro-L-arginine) vs. Control was evaluated on Tubuloglomerular feedback sensitivity and reactivity (turning point and delta Psf). Intratubular infusion of the nitric oxide synthase inhibitor L-NNA increased tubuloglomerular feedback sensitivity and reactivity, decreasing the turning point from 19.8 to 15.2 nl/min.
Synapse has enriched 10 related papers. Consider them for comparative context: